4-(4-trans-hydroxycyclohexyl)amino-2-p henyl-7h-pyrrolo [2, 3d]pyrimidine hydrogen mesylate and its polymorphic forms

Details for Australian Patent Application No. 2004232495 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Zorgdrager, Jan; Finner, Emil; Heinrich, Timo; Pahl, Axel; Verveer, Pieter C.; Luitjens, Bernd-Martin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004232495

PCT Pub. Number WO2004/094428

Priority 03101093.7 22.04.03 EP; 60/464,422 22.04.03 US

Filing date 21 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 22 April 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/094428 Priority application(s): WO2004/094428

22 April 2010 Application Accepted

  Published as AU-B-2004232495

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232514-Method of producing copper hydroxosulphates and copper fungicidal compositions containing same

2004232492-Natural products composites